- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07937267
Cytological Assessment of Donor-Site Healing After Free Gingival Grafting
Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery
An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.
At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.
All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.
For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Istanbul, Turecko (Türkiye)
- Nábor
- Biruni University
-
Kontakt:
- Ayşe Ege Selman
- Telefonní číslo: 902124448276
- E-mail: ayseegeselman@gmail.com
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Volunteering to participate in the study,
- Being at least 18 years of age,
- The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
- No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,
Exclusion Criteria:
- The presence of a systemic disease that would contraindicate surgical treatment,
- Uncontrolled diabetes (HbA1c > 7),
- Pregnancy or breastfeeding,
- Autoimmune and/or inflammatory diseases of the oral cavity,
- Active periodontal disease.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Řízení
|
Free gingival graft surgery |
|
Experimentální: Test
|
Free gingival graft surgery Suturing of chitosan sponge to the palatal donor site |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Palatal donor site tissue thickness:
Časové okno: Pre-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
Pre-operative
|
|
Palatal donor site tissue thickness:
Časové okno: immediate Post-operative
|
The thickness of the donor site will be measured using an endodontic reamer. |
immediate Post-operative
|
|
Palatal donor site tissue thickness:
Časové okno: day 10
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 10
|
|
Palatal donor site tissue thickness:
Časové okno: day 30
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 30
|
|
Palatal donor site tissue thickness:
Časové okno: day 90
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 90
|
|
Palatal donor site tissue thickness:
Časové okno: day 180
|
The thickness of the donor site will be measured using an endodontic reamer. |
day 180
|
|
Keratinization Index
Časové okno: day 3
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Keratinization Index
Časové okno: day 10
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Keratinization Index
Časové okno: day 30
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Keratinization Index
Časové okno: day 90
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Keratinization Index
Časové okno: day 180
|
Cells without nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
|
Superficial cell index
Časové okno: day 3
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 3
|
|
Superficial cell index
Časové okno: day 10
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 10
|
|
Superficial cell index
Časové okno: day 30
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 30
|
|
Superficial cell index
Časové okno: day 90
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 90
|
|
Superficial cell index
Časové okno: day 180
|
Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100 |
day 180
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Loss of sensation
Časové okno: Day 10
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 10
|
|
Loss of sensation
Časové okno: Day 30
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 30
|
|
Loss of sensation
Časové okno: Day 90
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 90
|
|
Loss of sensation
Časové okno: Day 180
|
To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping. |
Day 180
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- 2015-KAEK-80-23-44
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .